Benchling as Scientific Operating System
Discovery Loop
Benchling is becoming harder to route around because it is moving from being the place scientists write things down to the place experiments actually get run and interpreted. Once one system holds the protocol, triggers the instruments or workflows, ingests results as structured data, and helps decide the next experiment, it sits on the highest value part of the loop and becomes the natural control point for both humans and AI systems.
-
Benchling added this layer by bringing in ReSync Bio for compute and experiment workflow management across the DMTA cycle, and Sphinx Bio for live analysis of experimental data. That extends it from record keeping into active execution and iteration.
-
The installed base matters. Benchling already served about 1,200 customers and roughly 200,000 scientists, with more than half of the top 50 global biopharma companies on the platform. That makes orchestration and analysis easier to cross sell than a net new lab operating system.
-
Emerald Cloud Lab and Strateos own more of the physical lab layer. They let scientists remotely script, run, and analyze experiments through cloud labs and APIs. That makes them useful infrastructure for many AI stacks, but not the default system of record inside large biotech organizations.
The next battleground is who becomes the operating system for scientific iteration. If Benchling keeps tying protocol design, automation, analysis, and AI agents into the same workflow, new entrants will need to plug into Benchling rather than displace it, while cloud lab providers will be pushed to climb upward into planning and optimization.